NIXE 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 14
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1039002230111 -
GGREM
509022070028604 -
Código de barras
7898040327620
O que a fonte publica
- Detentor do registro
- FARMOQUÍMICA S/A
- Princípios ativos
- RIVAROXABANA
- Embalagem
- 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 14
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NIXE 20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 14",
"holder": "FARMOQUÍMICA S/A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898040327620"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "509022070028604",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.349.473/0001-58",
"priceRegime": "Regulado",
"productName": "NIXE",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "20 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 14",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "102.19",
"icms-12": "116.13",
"icms-17": "123.12",
"icms-18": "124.62",
"icms-19": "126.16",
"icms-20": "127.74",
"icms-21": "129.35",
"icms-22": "131.01",
"icms-23": "132.71",
"icms-17.5": "123.87",
"icms-19.5": "126.94",
"icms-20.5": "128.54",
"icms-22.5": "131.86",
"icms-12-alc": "114.73",
"icms-17-alc": "121.64",
"icms-18-alc": "123.13",
"icms-19-alc": "124.65",
"icms-20-alc": "126.20",
"icms-21-alc": "127.80",
"icms-22-alc": "129.44",
"icms-23-alc": "131.12",
"withoutTaxes": "100.96",
"icms-17.5-alc": "122.38",
"icms-19.5-alc": "125.42",
"icms-20.5-alc": "127.00",
"icms-22.5-alc": "130.28"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVAROXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "140.86",
"icms-12": "160.07",
"icms-17": "169.71",
"icms-18": "171.78",
"icms-19": "173.90",
"icms-20": "176.08",
"icms-21": "178.30",
"icms-22": "180.58",
"icms-23": "182.93",
"icms-17.5": "170.74",
"icms-19.5": "174.97",
"icms-20.5": "177.18",
"icms-22.5": "181.76",
"icms-12-alc": "158.61",
"icms-17-alc": "168.16",
"icms-18-alc": "170.22",
"icms-19-alc": "172.32",
"icms-20-alc": "174.46",
"icms-21-alc": "176.68",
"icms-22-alc": "178.94",
"icms-23-alc": "181.27",
"withoutTaxes": "139.58",
"icms-17.5-alc": "169.18",
"icms-19.5-alc": "173.39",
"icms-20.5-alc": "175.57",
"icms-22.5-alc": "180.10"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVAROXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1039002230111",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:509022070028604"